A higher bid for Healthscope Ltd?

Healthscope Ltd (ASX: HSO) is under a takeover offer from Brookfield, with an indicative price of $2.50 per share. Previously a consortium, of which Australian Super is a part, had offered $2.36 a share, the company is currently trading at $2.48.  A previous offer was closer to $2.00. The forward price-earnings-ratio (PER) at the time of writing is 24x, with the median PER for the industry at 20x.

Australian Super, which has an investment of $500 million or 14% holding in Healthscope, has said the company would not accept the Brookfield offer. Healthscope is one of Australia’s leading healthcare operators, with hospitals, pathology services and medical centres. Healthscope also has a substantial property portfolio as it owns many of the hospitals it operates.

As reported in The Australian newspaper, Credit Suisse’s US equity research team said that in situations like this with a bidding war, the price bias is likely to be up.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Rosemary Steinfort has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.